Fertility preservation in women

Non-Invasive Management of Gynecologic Disorders

Volumn , Issue , 2008, Pages 145-157

  Bianchi, Veronica ^a   Johnson, Joshua ^a   Seli, Emre ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79952660035     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.3109/9780203091425-14     Document Type: Chapter

References (97)

1. American Cancer Society. Cancer Facts & Figures 2001. Atlanta, GA: ACS, 2001.
2. Ries LAG, Percy CL, Bunin GR. Introduction. In: Ries LAG, Smith MA, Gurney JG, eds. Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995. Bethesda, MD: National Cancer Institute, 1999.
3. Bleyer WA. The impact of childhood cancer on the United States and the world. Cancer 1990; 40: 355-67.
4. Martin J, Hamilton B, Sutton P et al. Births: final data for 2002. Natl Vital Stat Rep December 2003; 52(10).
5. Oktay K, Buyuk E, Davis O et al. Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen. Hum Reprod 2003; 18: 90-5.
6. Oktay K, Buyuk E, Libertella N et al. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol 2005; 23: 4347-53.
7. Oktay K, Hourvitz A, Sahin G et al. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab 2006; 91: 3885-90.
8. Azim AA, Costantini-Ferrando M, Lostritto K, Oktay K. Relative potencies of anastrozole and letrozole to suppress estradiol in breast cancer patients undergoing ovarian stimulation before in vitro fertilization. J Clin Endocrinol Metab 2007; 92: 2197-200.
9. Son WY, Yoon SH, Yoon HJ, Lee SM, Lim JH. Pregnancy outcome following transfer of human blastocysts vitrified on electron microscopy grids after induced collapse of the blastocoele. Hum Reprod 2003; 18: 137-9.
10. Wang JX, Yap YY, Matthews CD. Frozen-thawed embryo transfer: influence of clinical factors on implantation rate and risk of multiple conception. Hum Reprod 2001; 16: 2316-19.
11. Senn A, Vozzi C, Chanson A, De Grandi P, Germond M. Prospective randomized study of two cryopreservation policies avoiding embryo selection: the pronucleate stage leads to a higher cumulative delivery rate than the early cleavage stage. Fertil Steril 2000; 74: 946-52.
12. Frederick JL, Ord T, Kettel LM et al. Successful pregnancy outcome after cryopreservation of all fresh embryos with subsequent transfer into an unstimulated cycle. Fertil Steril 1995; 64: 987-90.
13. Selick CE, Hofmann GE, Albano C et al. Embryo quality and pregnancy potential of fresh compared with frozen embryos - is freezing detrimental to high quality embryos? Hum Reprod 1995; 10: 392-5.
14. Sonmezer M, Oktay K. Fertility preservation in female patients. Hum Reprod Update 2004; 10: 251-66.
15. Centers for Disease Control. Assisted reproductive technology success rates. In: National Summary and Fertility Clinic Reports. Atlanta, GA: US Department of Health and Human Services, 2002.
16. Baysoy A, Serdaroglu H, Jamal H et al. Letrozole versus human menopausal gonadotrophin in women undergoing intrauterine insemination. Reprod Biomed Online 2006; 13: 208-12.
17. Bedaiwy MA, Forman R, Mousa NA, Al Inany HG, Casper RF. Cost-effectiveness of aromatase inhibitor cotreatment for controlled ovarian stimulation. Hum Reprod 2006; 21: 2838-44.
18. Chen C. Pregnancy after human oocyte cryopreservation. Lancet 1986; 1: 884-6.
19. Jackowski S, Leibo SP, Maxur P. Glycerol permeabilities of fertilized and infertilized mouse ova. J Exp Zool 1980; 212:329-41.
20. Leibo SP. Water permeability and its activation energy of fertilized and unfertilized mouse ova. J Membr Biol 1980; 53:179-88.
21. Matson PL, Graefling J, Junk SM, Yovich JL, Edirisinghe WR. Cryopreservation of oocytes and embryos: use of a mouse model to investigate effects upon zona hardness and formulate treatment strategies in an in-vitro fertilization programme. Hum Reprod 1997; 12: 1550-3.
22. Porcu E, Fabbri R, Seracchioli R et al. Birth of a healthy female after intracytoplasmic sperm injection of cryopreserved human oocytes. Fertil Steril 1997; 68: 724-6.
23. Polak de Fried E, Notrica J, Rubinstein M, Marazzi A, Gomez Gonzalez M. Pregnancy after human donor oocyte cryopreservation and thawing in association with intracytoplasmic sperm injection in a patient with ovarian failure. Fertil Steril 1998; 69:555-7.
24. Lassalle B, Testart J, Renard JP. Human embryo features that influence the success of cryopreservation with the use of 1, 2 propanediol. Fertil Steril 1985; 44: 645-51.
25. Leibo SP. Fundamental cryobiology of mouse ova and embryos. Ciba Found Symp 1977; 52: 69-96.
26. Mazur P. Freezing of living cells: mechanisms and implications. Am J Physiol 1984; 247: 125-42.
27. Rienzi L, Martinez F, Ubaldi F et al. Polscope analysis of meiotic spindle changes in living metaphase II human oocytes during the freezing and thawing procedures. Hum Reprod 2004; 19: 655-9.
28. Bianchi V, Coticchio G, Fava L, Flamigni C, Borini A. Meiotic spindle imaging in human oocytes frozen with a slow freezing procedure involving high sucrose concentration. Hum Reprod 2005; 20: 1078-83.
29. Coticchio G, De Santis L, Rossi G et al. Sucrose concentration influences the rate of human oocytes with normal spindle and chromosome configurations after slow-cooling cryopreservation. Hum Reprod 2006; 21: 1771-6.
30. Gook DA, Osborn SM, Johnston WI. Cryopreservation of mouse and human oocytes using 1, 2-propanediol and the configuration of the meiotic spindle. Hum Reprod 1993; 8:1101-9.
31. Borini A, Coticchio G, Flamigni C. Oocyte freezing: a positive comment based on our experience. Reprod Biomed Online 2003; 7: 120.
32. Fabbri R, Porcu E, Marsella T et al. Human oocyte cryopreservation:new perspectives regarding oocyte survival. Hum Reprod 2001; 16: 411-16.
33. Huang J, Tan SL, Chian RC. Fertility preservation for female. J Reprod Contracept 2006; 17: 1-20.
34. Borini A, Sciajno R, Bianchi V et al. Clinical outcome of oocyte cryopreservation after slow cooling with a protocol utilizing a high sucrose concentration. Hum Reprod 2006; 21: 512-17.
35. Levi Setti PE, Albani E, Novara PV, Cesana A, Morreale G. Cryopreservation of supernumerary oocytes in IVF/ICSI cycles. Hum Reprod 2006; 21: 370-5.
36. Oktay K, Cil PA, Bang H. Efficiency of oocyte cryopreservation:a meta-analysis. Fertil Steril 2006; 86: 70-80.
37. Paynter SJ, Borini A, Bianchi V et al. Volume changes of mature human oocytes on exposure to cryoprotectant solutions used in slow cooling procedures. Hum Reprod 2005; 20: 1194-9.
38. Bianchi V, Coticchio G, Distratis V et al. Differential sucrose concentration during dehydration (0.2 mol/l) and rehydration (0.3 mol/l) increases the implantation rate of frozen human oocytes. Reprod Biomed Online 2007; 14: 64-71.
39. Mazur P. Equilibrium, quasi-equilibrium, and nonequilibrium freezing of mammalian embryos. Cell Biophys 1990; 17: 53-92.
40. Rall WF. Factors affecting the survival of mouse embryos cryopreserved by vitrification. Cryobiology 1987; 24: 387-402.
41. Fahy GM. Vitrification. In: McGrath JJ, Diller KR, eds. Low Temperature Biotechnology: Emerging Applications and Engineering Contributions. New York: ASME, 1988.
42. Kasai M, Korni JH, Takakarmo A et al. A simple method for mouse embryo cryopreservation in a low toxicity vitrification solution, without appreciable loss of viability. J Reprod Fertil 1990; 89: 91-7.
43. Kuleshova L, Gianaroli L, Magli C, Ferraretti A, Trounson A. Birth following vitrification of a small number of human oocytes: case report. Hum Reprod 1999; 14: 3077-9.
44. Yoon TK, Chung HM, Lim JM et al. Pregnancy and delivery of healthy infants developed from vitrified oocytes in a stimulated in vitro fertilization-embryo transfer program. Fertil Steril 2000; 74: 180-1.
45. Antinori M, Licata E, Dani G et al. Cryotop vitrification of human oocytes results in high survival rate and healthy deliveries. Reprod Biomed Online 2007; 14: 72-9.
46. Kuwayama M, Vajta G, Kato O, Leibo S. Highly efficient vitrification method for cryopreservation of human oocytes. Reprod Biomed Online 2005; 11: 300-8.
47. Glode LM, Robinson J, Gould SF. Protection from cyclophosphamide- induced testicular damage with an analogue of gonadotropin-releasing hormone. Lancet 1981; 1: 1132-4.
48. Ataya K, Moghissi K. Chemotherapy-induced premature ovarian failure: mechanisms and prevention. Steroids 1989; 54: 607-26.
49. Ataya K, Rao LV, Lawrence E, Kimmel R. Luteinizing hormone- releasing hormone agonist inhibits cyclophosphamideinduced ovarian follicular depletion in rhesus monkeys. Biol Reprod 1995; 52: 365-72.
50. Ataya K, Pydyn E, Ramahi-Ataya A, Orton CG. Is radiationinduced ovarian failure in rhesus monkeys preventable by luteinizing hormone-releasing hormone agonists?: Preliminary observations. J Clin Endocrinol Metab 1995; 80: 790-5.
51. Blumenfeld Z, Avivi I, Linn S et al. Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy. Hum Reprod 1996; 11: 1620-6.
52. Blumenfeld Z, Avivi I, Ritter M, Rowe JM. Preservation of fertility and ovarian function and minimizing chemotherapyinduced gonadotoxicity in young women. J Soc Gynecol Invest 1999; 6: 229-39.
53. Blumenfeld Z, Shapiro D, Shteinberg M, Avivi I, Nahir M. Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemotherapy. Lupus 2000; 9: 401-5.
54. Blumenfeld Z, Dann E, Avivi I, Epelbaum R, Rowe JM. Fertility after treatment for Hodgkin’s disease [see Comment]. Ann Oncol 2002; 13 (Suppl 1): 138-47.
55. Recchia F, Sica G, De Filippi S et al. Goserelin as ovarian protection in the adjuvant treatment of premenopausal breast cancer: a phase II pilot study. Anticancer Drugs 2002; 13: 417-24.
56. Blumenfeld Z. Gynaecologic concerns for young women exposed to gonadotoxic chemotherapy. Curr Opin Obstet Gynecol 2003; 15: 359-70.
57. Blumenfeld Z. Ovarian cryopreservation versus ovarian suppression by GnRH analogues: primum non nocere. Hum Reprod 2004; 19: 1924-5.
58. Oktay K, Sonmezer M, Oktem O. ‘Ovarian cryopreservation versus ovarian suppression by GnRH analogues: primum non nocere’: Reply. Hum Reprod 2004; 19: 1681-3.
59. Danforth DR, Roberts A, Arbogast LK, Friedman CL. Follicular preservation during cyclophosphamide treatment:GnRH agonist vs antagonist. J Soc Gynecol Investig 2003; 10:135A.
60. McCall ML, Keaty EC, Thompson JD. Conservation of ovarian tissue in the treatment of carcinoma of the cervix with radical surgery. Am J Obstet Gynecol 1958; 75: 590-600.
61. Morice P, Castaigne D, Haie-Meder C et al. Laparoscopic ovarian transposition for pelvic malignancies: indications and functional outcomes. Fertil Steril 1998; 70: 956-60.
62. Bisharah M, Tulandi T. Laparoscopic preservation of ovarian function: an underused procedure. Am J Obstet Gynecol 2003; 188: 367-70.
63. Morice P, Thiam-Ba R, Castaigne D et al. Fertility results after ovarian transposition for pelvic malignancies treated by external irradiation or brachytherapy. Hum Reprod 1998; 13: 660-3.
64. Oktay K, Buyuk E, Rosenwaks Z, Rucinski J. A technique for transplantation of ovarian cortical strips to the forearm. Fertil Steril 2003; 80: 193-8.
65. Gosden RG, Baird DT, Wade JC, Webb R. Restoration of fertility to oophorectomised sheep by ovarian autografts stored at -196°C. Hum Reprod 1994; 9: 597-603.
66. Salle B, Demirci B, Franck M et al. Normal pregnancies and live births after autograft of frozen-thawed hemi-ovaries into ewes. Fertil Steril 2002; 77: 403-8.
67. Sztein J, Sweet H, Farley J, Mobraaten L. Cryopreservation and orthotopic transplantation of mouse ovaries: new approach in gamete banking. Biol Reprod 1998; 58: 1071-4.
68. Radford JA, Lieberman BA, Brison DR et al. Orthotopic reimplantation of cryopreserved ovarian cortical strips after highdose chemotherapy for Hodgkin’s lymphoma. Lancet 2001; 357: 1172-5.
69. Donnez J, Dolmans MM, Demylle D et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 2004; 364: 1405-10.
70. Oktay K, Tilly J. Livebirth after cryopreserved ovarian tissue autotransplantation. Lancet 2004; 364: 2091-2.
71. Meirow D, Levron J, Eldar-Geva T et al. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med 2005; 353:318-21.
72. Meirow D, Levron J, Eldar-Geva T et al. Monitoring the ovaries after autotransplantation of cryopreserved ovarian tissue:endocrine studies, in vitro fertilization cycles, and live birth. Fertil Steril 2007; 87: 418.e7-e15.
73. Oktay K, Economos K, Kan M et al. Endocrine function and oocyte retrieval after autologous transplantation of ovarian cortical strips to the forearm [see Comment]. JAMA 2001; 286: 1490-3.
74. Oktay K, Buyuk E, Veeck L et al. Embryo development after heterotopic transplantation of cryopreserved ovarian tissue [see Comment]. Lancet 2004; 363: 837-40.
75. Shaw JM, Bowles J, Koopman P, Wood EC, Trounson AO. Fresh and cryopreserved ovarian tissue samples from donors with lymphoma transmit the cancer to graft recipients. Hum Reprod 1996; 11: 1668-73.
76. Bosma GC, Custer RP, Bosma MJ. A severe combined immunodeficiency mutation in the mouse. Nature 1983; 301: 527-30.
77. Oktay K, Newton H, Gosden R. Transplantation of cryopreserved human ovarian tissue results in follicle growth initiation in SCID mice. Fertil Steril 2000; 73: 599-603.
78. Weissman A, Gotlieb L, Colgan T et al. Preliminary experience with subcutaneous human ovarian cortex transplantation in the NOD-SCID mouse. Biol Reprod 1999; 60: 1462-7.
79. Revel A, Davis VJ, Casper RF. Ovarian cortex cryopreservation in pediatric and adolescent medicine. J Pediatr Adolesc Gynecol 2000; 13: 95.
80. Eppig JJ, O’Brien MJ. Development in vitro of mouse oocytes from primordial follicles. Biol Reprod 1996; 54: 197-207.
81. O’Brien MJ, Pendola JK, Eppig JJ. A revised protocol for in vitro development of mouse oocytes from primordial follicles dramatically improves their development competence. Biol Reprod 2003; 68: 1682-6.
82. Qvist R, Blackwell LF, Bourne H, Brown JB. Development of mouse ovarian follicles from primary to preovulatory stages in vitro. J Reprod Fertil 1990; 89: 169-80.
83. Nayudu PL, Osborn SM. Factors influencing the rate of preantral and antral growth of mouse ovarian follicles in vitro. J Reprod Fertil 1992; 95: 349-62.
84. Cortvrindt R, Smitz J. Early preantral mouse follicle in vitro maturation: oocyte growth, meiotic maturation and granulosacell proliferation. Theriogenology 1998; 49: 845-59.
85. Cortvrindt R, Smitz J, Van Steirteghem AC. In vitro maturation, fertilization and embryo development of immature oocytes from early preantral follicles from prepubertal mice in a simplified culture system. Hum Reprod 1996; 11: 2656-66.
86. Spears N, Boland NI, Murray AA, Gosden RG. Mouse oocytes derived from in vitro grown primary ovarian follicles are fertile. Hum Reprod 1994; 9: 527-32.
87. Newton H, Illingworth P. In vitro growth of murine pre-antral follicles after isolation from cryopreserved ovarian tissue. Hum Reprod 2001; 16: 423-9.
88. Segino M, Ikeda M, Hirahara F, Sato K. In vitro follicular development of cryopreserved mouse ovarian tissue. Reproduction 2005; 130: 187-92.
89. Sztein JM, O’Brien MJ, Farley JS, Mobraaten LE, Eppig JJ. Rescue of oocytes from antral follicles of cryopreserved mouse ovaries: competence to undergo maturation, embryogenesis, and development to term. Hum Reprod 2000; 15:567-71.
90. Yin H, Wang X, Kim SS et al. Transplantation of intact rat gonads using vascular anastomosis: effects of cryopreservation, ischaemia and genotype. Hum Reprod 2003; 18:1165-72.
91. Jeremias E, Bedaiwy MA, Nelson D, Biscotti CV, Falcone T. Assessment of tissue injury in cryopreserved ovarian tissue. Fertil Steril 2003; 79: 651-3.
92. Bedaiwy MA, Jeremias E, Gurunluoglu R et al. Restoration of ovarian function after autotransplantation of intact frozenthawed sheep ovaries with microvascular anastomosis. Fertil Steril 2003; 79: 594-602.
93. Jeremias E, Bedaiwy MA, Gurunluoglu R et al. Heterotopic autotransplantation of the ovary with microvascular anastomosis:a novel surgical technique. Fertil Steril 2002; 77:1278-82.
94. Wang X, Chen H, Yin H et al. Fertility after intact ovary transplantation. Nature 2002; 415: 385.
95. Arav A, Revel A, Nathan Y et al. Oocyte recovery, embryo development and ovarian function after cryopreservation and transplantation of whole sheep ovary. Hum Reprod 2005; 20:3545-59.
96. Bedaiwy MA, Hussein MR, Biscotti C, Falcone T. Cryopreservation of intact human ovary with its vascular pedicle. Hum Reprod 2006; 21: 3258-69.
97. Martinez-Madrid B, Camboni A, Dolmans MM et al. Apoptosis and ultrastructural assessment after cryopreservation of whole human ovaries with their vascular pedicle. Fertil Steril 2007; 87: 1153-65.